---  
layout: startup_page  
title: "Neurosterix"  
id: "neurosterix.com"  
permalink: "/neurosterixneurosterix.com04032024/"  
website: "https://www.neurosterix.com/"  
funding_round: "Series A"  
funding_amount: "$63M"  
investors: "Perceptive Xontogeny Venture Fund II, Perceptive Life Sciences Fund, Acorn Bioventures"  
about: "Neurosterix is a biopharmaceutical company developing allosteric modulator therapeutics for neurological disorders. Its lead program is an M4 PAM for schizophrenia, leveraging a proprietary high-throughput drug discovery platform acquired from Addex Therapeutics. The company aims to improve efficacy and safety of treatments through this innovative approach."  
markets: "Biopharmaceutical, Neuroscience, Pharmaceutical, Biotechnology Research, Drug Discovery"  
hq: "Geneva, Geneva, Switzerland"  
founded_year: "2024"  
linkedin: "https://www.linkedin.com/company/neurosterix"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/neurosterix?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase"  
pitchbook: "https://pitchbook.com/profiles/company/593003-80"  

date_display: "03-Apr-2024"  
date: "2024-04-03"

# SEO Optimization  
meta_title: "Neurosterix - Series A Funding ($63M)"  
meta_description: "Neurosterix, Neurosterix is a biopharmaceutical company developing allosteric modulator therapeutics for neurological disorders. Its lead program is an M4 PAM for ..."  
meta_keywords: "Neurosterix, Biopharmaceutical, Neuroscience, Pharmaceutical, Biotechnology Research, Drug Discovery, Series A funding"  
canonical_url: "https://startup.projectstartups.com/neurosterixneurosterix.com04032024/"  
---